Rheumatoid Arthritis
Research Study
Researchers at Northwestern Medicine are evaluating a possible cell therapy for people with rheumatoid arthritis who do not benefit from the standard therapies. Join our compensated study today!
Fast Facts
moderate to severe rheumatoid arthritis
unsuccessful prior treatments
Ages 18-70
compensation provided
conducted in Chicago, IL
Study Background
Researchers at Northwestern Medicine are investigating a possible new option for people with rheumatoid arthritis (RA).
The trial cell therapy is made from a participant’s own cells. By adding new DNA (instructions that tell cells how to do their job) to certain immune cells, cell therapy may help reduce inflammation, joint damage, and other symptoms in people with RA.
Findings from this clinical research study may determine if your own cells can be directed to manage RA and improve your condition.
The trial lasts about 13 months. Participants will attend approximately 5-6 screening visits, 16 treatment study visits, and follow-up visits.
Further research today and join our compensated study!
Study Background
Researchers at Northwestern Medicine are investigating a possible new option for people with rheumatoid arthritis (RA).
The trial cell therapy is made from a participant’s own cells. By adding new DNA (instructions that tell cells how to do their job) to certain immune cells, cell therapy may help reduce inflammation, joint damage, and other symptoms in people with RA.
Findings from this clinical research study will determine if your own cells can be directed to manage RA and improve your condition.
The trial lasts about 11 months. Participants will attend approximately 5-6 screening visits, 16 treatment study visits, and follow-up visits.
Further research today and join our compensated study!
Additional Information
You may qualify for this study if you meet the following criteria.
Key Criteria:
- Ages 18-70
- Moderate to severe rheumatoid arthritis
- Unsuccessful prior treatments
- Diagnosed in adulthood
Once enrolled, this study involves the following periods:
- Screening (about 4 weeks)
- Complete screening assessment for about 4 weeks to find out if you qualify for the trial
- Includes a joint biopsy (a needle is used to collect a sample of synovial fluid and tissue)
- Cell Therapy Preparation (about 6 weeks, but up to 6 months is allowed)
- Apheresis (blood is drawn into an approved apheresis machine to separate the cells used for the cell therapy)
- Pre-trial health assessment to confirm that it is safe to receive the cell therapy
- Cell Therapy and Trial Health Assessments (about 11 months)
- If you qualify, you will receive the cell therapy as a one-time IV infusion on Day 1 of the trial
- You will be asked to stay overnight at the trial clinic, so
the trial doctor and staff can monitor your health closely - Receive trial health assessments for 48 weeks (about
11 months) that include, but are not limited to,
the following:- Joint biopsy (a needle is used to collect a sample of
synovial fluid and tissue) - Vital signs, blood tests, questionnaires, urine tests,
heart tests, and physical exams
- Joint biopsy (a needle is used to collect a sample of
- Long-term Follow-up (up to 15 years)
- Continue to the long-term follow-up period for up to
15 years (you will receive more information from the trial staff)
- Continue to the long-term follow-up period for up to
Compensation is provided up to $2900 for your participation.